Centre for Bio-Separation Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India; School of Basic and Applied Sciences, Dayananda Sagar University, Bangalore, Karnataka, 560068, India.
Animal Facility, ICMR-National Institute of Nutrition, Hyderabad, Telangana, 50000, India.
J Ethnopharmacol. 2025 Jan 30;337(Pt 1):118849. doi: 10.1016/j.jep.2024.118849. Epub 2024 Sep 23.
Natural products have emerged as a novel source in the management of non-communicable diseases, more so in diabetes mellitus and its comorbidities. Aloe vera is widely recognized for its anti-hyperglycemic and anti-hyperlipidemic properties and numerous researchers have identified component (s) from Aloe vera attributing to these therapeutic effects.
The current work was undertaken to gain insight into the protective effect of Aloe vera (L.) Burm. f. extract to study the cytoarchitecture/histopathological alterations in the target organs in mutant Obese WNIN/GR-Ob rats that were made frank diabetic with streptozotocin.
Rats were divided into five groups. 1)WNIN-GR-Ob/control group 2)WNIN-GR-Ob treated with STZ 3)WNIN-GR-Ob + STZ + Sitagliptin 4)WNIN-GR-Ob + STZ + Aloe vera 5)WNIN-GR-Ob/control group + Aloe vera. Histopathological analysis of the pancreas, kidney, liver, and adipocytes was done after 4 weeks of treatment.
The histopathological examination of STZ-induced diabetic rats revealed significant changes in all the vital organs including cell infiltration, degeneration, and necrosis. Treatment with A. vera negated most of the histopathological changes seen in STZ induced rats. Sitagliptin-which served as a positive control in the present study-reversed the alterations seen in streptozotocin rats.
Considering the hypoglycaemic and hypolipidemic activities of Aloe vera that have been previously demonstrated by us, the present study further re-instates the therapeutic efficacy of Aloe vera towards vital organs. It was able to restore islet cells and reduce β-cell damage. In addition, it was also able to aid in kidney tubular regeneration and reverse the degenerative changes brought on by streptozotocin on liver. Further, Aloe vera treated group exhibited moderate hyperplasia with decreased size of adipocytes and reduced macrophage infiltration. Thus, our findings advocate its application as an important nutraceutical in the therapeutic management of diabetes mellitus and associated complications.
天然产物已成为治疗非传染性疾病(尤其是糖尿病及其合并症)的新来源。众所周知,芦荟具有降血糖和降血脂作用,许多研究人员已经从芦荟中鉴定出具有这些治疗作用的成分。
本研究旨在深入了解芦荟(L.)提取物的保护作用,以研究突变肥胖 WNIN/GR-Ob 大鼠在链脲佐菌素作用下发生糖尿病时靶器官的细胞结构/组织病理学改变。
将大鼠分为五组。1)WNIN-GR-Ob/对照组 2)WNIN-GR-Ob 用 STZ 处理 3)WNIN-GR-Ob+STZ+西他列汀 4)WNIN-GR-Ob+STZ+芦荟 5)WNIN-GR-Ob/对照组+芦荟。治疗 4 周后对胰腺、肾脏、肝脏和脂肪细胞进行组织病理学分析。
STZ 诱导的糖尿病大鼠的组织病理学检查显示所有重要器官均发生显著变化,包括细胞浸润、变性和坏死。芦荟治疗否定了 STZ 诱导大鼠中所见的大多数组织病理学变化。西他列汀-在本研究中作为阳性对照-逆转了链脲佐菌素大鼠的改变。
鉴于我们之前已经证明的芦荟的降血糖和降血脂作用,本研究进一步证实了芦荟对重要器官的治疗功效。它能够恢复胰岛细胞并减少β细胞损伤。此外,它还能够帮助肾小管再生并逆转链脲佐菌素对肝脏造成的退行性变化。此外,芦荟治疗组表现出适度的增生,脂肪细胞体积减小,巨噬细胞浸润减少。因此,我们的研究结果主张将其作为糖尿病及其相关并发症治疗管理的重要营养保健品应用。